JW Pharmaceutical Corp (001067.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7001062009
JW Pharmaceutical Corp financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 719.38 bn KRW | 775.30 bn KRW |
| Gross profit | 323.50 bn KRW | 359.31 bn KRW |
| Operating income | 82.73 bn KRW | 94.46 bn KRW |
| EBIT | 92.45 bn KRW | 93.26 bn KRW |
| Net income | 65.04 bn KRW | 61.51 bn KRW |
| Diluted EPS – continuing operations | 2,804.17 KRW | 2,727.83 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About JW Pharmaceutical Corp
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
More stocks
- Liberty Capital Corp/NV (GLIBK)
- Kale Environmental Technology (Shanghai) Corporation (301070.SZ)
- ASTEC INDUSTRIES INC (ASTE)
- TripAdvisor, Inc. (TRIP)
- Radiant Opto-Electronics Corp (6176.TW)
- PixArt Imaging (3227.TWO)
- Shanghai Research Institute of Building Sciences Group Co. Ltd A (603153.SS)
- Emdoor Information Co. Ltd. A (001314.SZ)
- TTET Union Corp (1232.TW)
- Smarter Microelectronics (Guangzhou) Co. Ltd. A (688512.SS)
- Apex Dynamics Inc. (4583.TW)
- SP Group A/S (SPG.CO)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.